Skip to main content

Molecular Dynamics simulations COMMON MISTAKES

 




Once, I thought Molecular Dynamics simulations were simple:

Run the simulation → generate RMSD plot → write paper.

Then one day, I realized something uncomfortable…

A simulation can look “perfect” and still be completely wrong.

I’ve seen:
❌ proteins explode because of bad protonation
❌ beautiful trajectories with incorrect force fields
❌ “stable complexes” that were just equilibration artifacts

That’s when I understood:

MD is not about making movies of atoms.
It’s about extracting physically meaningful insights.

After working with cryo-EM structures, oligomeric assemblies, docking, PCA/FEL analysis, and long-timescale simulations, I started noticing the same mistakes appearing again and again across beginner and sometimes even published MD studies.

So I created this infographic:

🔥 Top 10 Common Mistakes in MD Simulations
(+ practical solutions for each)

Whether you use GROMACS, Desmond, AMBER, NAMD, or OpenMM, these pitfalls are incredibly common in:
• protein simulations
• ligand binding studies
• membrane systems
• cryo-EM refinement workflows
• MM/PBSA projects

If you work in:
🧬 Structural Biology
💊 Drug Discovery
🖥 Computational Biophysics
🔬 Cryo-EM
📊 Bioinformatics

…this may save you weeks or even months of wrong interpretation.

Which mistake do you think is the MOST common in published MD papers?

Mine would be:
👉 Overinterpreting RMSD and PCA without validating the biology.

Comments

Popular posts from this blog

Curated Compendium of Drug Discovery

  Drug discovery is a multidisciplinary process that integrates biology, chemistry, pharmacology , and cutting-edge technologies to identify and develop new therapeutic agents. From target identification to lead optimization and clinical evaluation, each stage requires precision, innovation, and collaboration. A curated list of drug discovery resources provides researchers, students, and professionals with a structured pathway to explore advancements, tools, and strategies that shape modern therapeutics. This compilation serves as a gateway to understanding the evolution of drug discovery, recent breakthroughs, and future directions, fostering knowledge-sharing and accelerating translational research. Databases and Chemical Libraries General Compound Libraries DrugBank  - Comprehensive data on approved and investigational drugs. ZINC  - Free compounds for screening. ChemSpider  - Chemical structures and data. DrugSpaceX  - Chemical and biological spaces. Mcule ...

Understanding NMR Spectroscopy and Chemical Shift Ranges for Functional Groups

  Nuclear Magnetic Resonance ( NMR ) spectroscopy is one of the most powerful analytical tools in pharmaceutical chemistry. It helps chemists determine the structure, purity, and chemical environment of molecules by analyzing the behavior of nuclei (commonly ¹H or ¹³C ) when exposed to a strong magnetic field. In proton NMR ( ¹H-NMR ), the chemical shift (δ, in ppm) provides information about the type of hydrogen atoms present in a compound and their surrounding electronic environment. Depending on nearby atoms and functional groups, signals appear in specific regions of the spectrum — often referred to as upfield (shielded, lower δ values) or downfield (deshielded, higher δ values). The image above summarizes the characteristic δ ranges for different functional groups in ¹H-NMR. Let us break it down systematically: 1. Downfield Region (δ 12 – 6 ppm) Hydrogens in this region are strongly deshielded due to electronegative atoms or Ï€-bond systems. Carboxylic Acids (–COOH) : δ 1...

Pushing the boundaries of computational drug discovery at Isomorphic Labs

  The Isomorphic Labs Drug Design Engine (IsoDDE) has unlocked a new frontier in in-silico drug design, representing a significant evolution beyond AlphaFold 3. What IsoDDE delivers: 🔹 Massive accuracy leap on unconstrained structure prediction The engine more than doubles AlphaFold 3's accuracy on extremely challenging protein-ligand prediction tasks — including systems far outside the training distribution. 🔹 Best-in-class binding affinity prediction IsoDDE predicts how strongly small molecules bind to targets with accuracy that exceeds gold-standard physics-based methods, at a fraction of the computational cost and time. 🔹 Blind identification of novel binding pockets Even without existing structural data, the engine reveals previously unseen binding sites — just from an amino acid sequence — enabling drug designers to explore entirely new chemical action spaces. 🔹 Expanded support for complex biologics Beyond small molecules, the engine boosts prediction fidelity for...